Status:
COMPLETED
Skin Care for Cancer Patients: A Product Satisfaction Survey
Lead Sponsor:
Northwestern University
Conditions:
Skin Toxicity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being done because the investigators would like to evaluate product satisfaction of three test products (product A, product B, product C) that are available at any drug store. This will ...
Detailed Description
The primary objective of this study is to evaluate product satisfaction of the following test articles A, B, and C: Lindi Skin soothing balm (product A), Lindi Skin face serum (product B), and Lindi S...
Eligibility Criteria
Inclusion
- Subjects who are at least 18 years of age.
- Subjects who have the willingness and ability to understand and provide informed consent to participate in the study and are able to communicate with the investigator.
- Subjects who are seen in the SERIES clinic or Lurie Cancer Center and who are receiving chemotherapy and/or radiation treatment for malignancy
- Subjects who have grade \<2 skin toxicity based on NCI-CTCAE v3.0 scale.
- Subjects who are routine cosmetics users
Exclusion
- Under 18 years of age.
- Known allergy to any of the ingredients in the assigned products (Appendix C).
- Subjects who have grade 2,3,4 skin toxicity based on NCI-CTCAE v3.0 scale.
- Subjects who are pregnant, breast feeding, or those who are planning on becoming pregnant during test period.
- Subjects who use multiple topical agents on study areas
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00871429
Start Date
March 1 2009
End Date
August 1 2010
Last Update
March 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Department of Dermatology
Chicago, Illinois, United States, 60611